|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 97, 764-770, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
V Videm, E Fosse, TE Mollnes, O Ellingsen, T Pedersen and H Karlsen
Complement activation was studied in vitro with six different membrane and
bubble oxygenators for cardiopulmonary bypass. There was a similar increase
in terminal (C5 to C9) activation with all oxygenators (p less than 0.001),
ranging from 281% (117% to 444%) to 453% (225% to 680%) after 60 minutes
(median and 95% confidence intervals). C3 activation was not observed with
a hollow fiber membrane and a soft shell bubble oxygenator. On the other
hand, a capillary membrane, a sheet membrane, a nonporous membrane, and a
hard shell bubble oxygenator all induced a similar increase in C3
activation (p less than 0.01), ranging from 107% (23% to 346%) to 272% (88%
to 395%) after 60 minutes. The differences in C3 activation could not be
explained by the blood contact materials or any other single factor known
to induce activation, which suggests that overall complement activation
during cardiopulmonary bypass is a multifactorial effect. The tubing set
per se induced only minor C3 activation but contributed to the overall
formation of terminal complement complex. The study further indicates that
an arterial line blood filter prevents activated neutrophils from being
reinfused to the patient and should be used regardless of type of
oxygenator.
ARTICLES
Different oxygenators for cardiopulmonary bypass lead to varying degrees of human complement activation in vitro
Institute for Experimental Medical Research, University of Oslo, Norway.
This article has been cited by other articles:
![]() |
S. T Baksaas, V. Videm, E. Fosse, H. Karlsen, T. Pedersen, T. E Mollnes, T. A Hagve, and J. L Svennevig In vitro evaluation of new surface coatings for extracorporeal circulation Perfusion, January 1, 1999; 14(1): 11 - 19. [Abstract] [PDF] |
||||
![]() |
I Welters, T Menges, M Ballesteros, A Sablotzki, G Gorlach, and G Hempelmann Acute phase and opsonin response in cardiac surgery patients: influence of underlying cardiac disease Perfusion, December 1, 1998; 13(6): 447 - 454. [Abstract] [PDF] |
||||
![]() |
P. Hornick and A. George Blood contact activation: pathophysiological effects and therapeutic approaches Perfusion, January 1, 1996; 11(1): 3 - 19. [PDF] |
||||
![]() |
M. Ranucci, S. Cirri, D. Conti, A. Ditta, A. Boncilli, A. Frigiola, and L. Menicanti Beneficial Effects of Duraflo II Heparin-Coated Circuits on Postperfusion Lung Dysfunction Ann. Thorac. Surg., January 1, 1996; 61(1): 76 - 81. [Abstract] [Full Text] |
||||
![]() |
E. Ovrum, T. E. Mollnes, E. Fosse, E. A. Holen, G. Tangen, M. Abdelnoor, M.-A. L. Ringdal, R. Oystese, and P. Venge COMPLEMENT AND GRANULOCYTE ACTIVATION IN TWO DIFFERENT TYPES OF HEPARINIZED EXTRACORPOREAL CIRCUITS J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1623 - 1632. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |